DENVER, Dec. 14, 2017 /PRNewswire/ -- The following
media statement is attributable to DaVita (NYSE: DVA).
We take full ownership and
continue to embrace transparency and rigorous compliance.
DaVita is proud that its team
discovered and self-disclosed these issues to the federal
government in 2015 and 2016 and cooperated with the government in
resolving them. As the DOJ said in its announcement, this
settlement reflects the government's "willingness to work with
providers who review their own practices and make appropriate
self-disclosures." These amounts have been paid or previously
accrued.
DaVita launched the country's
first kidney care focused pharmacy over ten years ago and this
innovative approach successfully addressed important unmet clinical
needs of tens of thousands of kidney care patients at DaVita and
elsewhere.
About DaVita Inc.
DaVita Inc., a Fortune 500® company,
is the parent company of DaVita Kidney
Care and DaVita Medical Group. DaVita Kidney Care is a leading provider of
kidney care in the United States,
delivering dialysis services to patients with chronic kidney
failure and end-stage renal disease. As of September 30, 2017, DaVita Kidney Care operated or provided
administrative services at 2,470 outpatient dialysis centers
located in the United States
serving approximately 218,200 patients. The company also operated
230 outpatient dialysis centers located in 11 countries outside
the United States. DaVita Medical
Group manages and operates medical groups and affiliated physician
networks in California,
Colorado, Florida, Nevada, New
Mexico, and Washington in
its pursuit to deliver excellent-quality health care in a dignified
and compassionate manner. DaVita Medical Group's teammates,
employed clinicians and affiliated clinicians provided care for
approximately 1.7 million patients. For more information, please
visit DaVita.com/About.
Contact Information
Skip
Thurman
Skip.Thurman@davita.com
(303) 876-6610
View original content with
multimedia:http://www.prnewswire.com/news-releases/davita-kidney-care-issues-statement-about-davita-rx-settlement-300571751.html
SOURCE DaVita